A ‘Speed-Dating’ Model of Wound Care? Rapid, High-Volume Assessment of Patients With Diabetes in a Multidisciplinary Foot Wound Clinic

Abstract

Background Diabetes is a major risk factor for foot ulceration and leg amputation, but the effect of intensive glycaemic control on wound healing is unknown. While an interdisciplinary approach has been shown to be important in the management of diabetic foot ulcer (DFU), there is no standardised definition of such an interdisciplinary team.

Objective To investigate the role of an opportunistic, rapid-access, inter-disciplinary model of diabetes care at a foot wound clinic.

Methods A retrospective case-control study of patients with DFUs attending a diabetes foot wound clinic over a 6-month period. Outcomes in patients who were seen by a rapid-access interdisciplinary team (RAIT) consisting of an endocrinologist, diabetes educator and dietician during the standard wound care those who were not seen by this team were compared.

Results Fifty-five patients were seen by the RAIT and 64 control patients were not seen by this team during their attendance of a diabetes foot wound clinic. Patients in the intervention group had non-significantly higher baseline HbA1c and a significantly larger proportion were active cigarette smokers. Both groups achieved comparable reduction in the total number of DFUs per patient (p=0.971). Patients in the intervention group had a 60.1% reduction in wound size compared to 52.4% reduction in control group (p=0.526).

Conclusion Our study shows that the use of a rapid-access interdisciplinary team to assess and manage patients’ diabetes in a foot wound clinic is feasible. Patients with higher-risk diabetes foot wounds exposed to RAIT had comparable wound healing outcomes to lower risk patients.

Key words

diabetes autoimmunity - peripheral arterial disease cardiovascular incidences - neuropathy

Publication History

Received: 03 February 2020
Received: 29 March 2020

Accepted: 02 April 2020

Article published online:
07 May 2020

• References

• 1 Daves WA, Norman PE, Bruce DG. et al. Predictors, consequences and costs of diabetes-related lower extremity amputation complicating type 2 diabetes: The Fremantle Diabetes Study. Diabetologia 2006; 49: 2634-2641
• 2 Boulton AJ, Armstrong DG, Albert SF. et al. Comprehensive foot examination and risk assessment: A report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care 2008; 31: 1679-1685
• 3 Fernando ME, Seneviratne RM, Tan YM. et al. Intensive versus conventional glycaemic control for treating diabetic foot ulcers. Cocchrane Database Syst Rev 2016; 13: CD010764
• 4 UK Prospective Diabetes Study Group Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853
• 5 Christman AL, Selvin E, Margolis DJ. et al. Hemoglobin A1c predicts healing rate in diabetic wounds. J Invest Dermatol 2011; 131: 2121-2127
• 6 Zhou ZY, Liu YK, Chen HL. et al. HbA1c and lower extremity amputation risk in patients with diabetes: a meta-analysis. Int J Low Extrem Wounds 2015; 14: 168-177
• 7 Rai NK, Suryabhan Ansari M. et al. Effect of glycaemic control on apoptosis in diabetic wounds. J Wound Care 2005; 14: 277-281
• 8 Jafar N, Edriss H, Nugent K. The effect of short-term hyperglycemia on the innate immune system. Am J Med Sci 2016; 351: 201-211
• 9 Callaghan BC, Little AA, Feldman EL. et al. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev. 2012: CD007543
• 10 Lavery LA, Davis KE, Berriman SJ. et al. WHS guidelines update: Diabetic foot ulcer treatment guidelines. Wound Repair Regen 2016; 24: 112-126
• 11 Schaper NC, Van Netten JJ, Apelqvist J. et al International Working Group on the Diabetic Foot (IWGDF). Prevention and management of foot problems in diabetes: A summary guidance for daily practice 2015, based on the IWGDF guidance documents. Diabetes Res Clin Pract 2017; 124: 84-92
• 12 Berger JS, Hochman J, Lobach I. et al. Modifiable risk factor burden and the prevalence of peripheral artery disease in different vascular territories. J Vasc Surg 2013; 58: 673-681
• 13 Van Netten JJ, Price PE, Monteiro-Soares M. et al. Prevention of foot ulcers in the at-risk patient with diabetes: A systematic review. Diabetes Metab Res Rev 2016; 32 Suppl 1 84-98
• 14 Williams LH, Rutter CM, Katon WJ. et al. Depression and incident diabetic foot ulcers: A prospective cohort study. Am J Med 2010; 123: 748-754. e3
• 15 Everett E, Mathioudakis N. Update on management of diabetic foot ulcers. Ann NY Acad Sci 2018; 1411: 153-165
• 16 Gottrup F, Holstein P, Jørgensen B. et al. A new concept of a multidisciplinary wound healing center and a national expert function of wound healing. Arch Surg 2001; 136: 765-772
• 17 Western Sydney Diabetes. Taking the Heat Out of Our Diabetes Hotspot. September 2017 https://www.westernsydneydiabetes.com.au/themes/default/basemedia/content/files/WSD_TakingHeat_DiabetesHotspot.pdf(last accessed December 1, 2019)
• 18 Sung J, Padmanabhan S, Gurung S. et al. SGLT2 inhibitors and amputation risk: Real-world data from a diabetes foot wound clinic. J Clin Transl Endocrinol 2018; 13: 46-47
• 19 Fife CE, Horn SD, Smout RJ. et al. A predictive model for diabetic foot ulcer outcome: The wound healing index. Adv Wound Care (New Rochelle) 2016; 5: 279-287